Describe the scientific basis, composition and use of oral rehydration therapy.
Scientific Basis
Oral rehydration therapy corrects the dehydration of acute diarrhoea using an oral solution of glucose and electrolytes, exploiting the sodium-glucose cotransporter (SGLT1) of the intestinal brush border.
In secretory diarrhoea (cholera, enterotoxigenic E. Coli), the toxin drives chloride and water secretion from crypt cells → But the SGLT1 cotransporter on villous cells remains intact → glucose and sodium are absorbed together through this carrier, in a fixed 1:1 relationship → Sodium absorption creates an osmotic gradient → water follows passively → Absorption therefore continues despite ongoing secretion, and the net balance is restored
CLINICAL PEARL
The whole method rests on one fact: the absorptive pathway survives the illness that destroys the secretory balance. Toxin-mediated diarrhoea switches on secretion but leaves the glucose-coupled sodium carrier working — so giving glucose with salt turns that carrier on and pulls water back in. Salt water alone will not do it, and sugar water alone will not do it; the two together will. It has been called one of the most important medical advances of the twentieth century, and it costs almost nothing.
Composition
| Constituent | WHO reduced-osmolarity ORS | Purpose |
|---|---|---|
| Sodium | 75 mmol/L | Replaces the chief cation lost |
| Glucose | 75 mmol/L | Drives sodium absorption through SGLT1 — the equimolar ratio matters, and more glucose is not better |
| Potassium | 20 mmol/L | Replaces potassium losses, which are proportionally large in children and cause ileus and weakness if uncorrected |
| Chloride | 65 mmol/L | Anion |
| Citrate | 10 mmol/L | Corrects the metabolic acidosis; replaced bicarbonate because it is more stable in storage |
| Total osmolarity | 245 mOsm/L | Reduced from the original 311 — the lower osmolarity reduces stool output, vomiting and the need for unscheduled intravenous fluid |
Use and the Rest of Management
- Give ORS after each loose stool — roughly 50 to 100 mL in children under 2 and 100 to 200 mL in older children, and as much as the patient will drink in adults
- Continue feeding throughout, including breastfeeding — withholding food prolongs the illness and worsens nutrition; this reversed decades of contrary advice
- Zinc 10 to 20 mg daily for 14 days in children reduces the duration and severity of the episode and the incidence of further episodes over the next 2 to 3 months
- Intravenous fluid (Ringer lactate) is needed only for severe dehydration, shock, persistent vomiting or ileus; oral therapy suffices for the great majority
- Antibiotics only for specific indications — cholera, dysentery, typhoid, giardiasis, amoebiasis; most acute diarrhoea is viral
- Antimotility drugs have NO place in childhood diarrhoea
Applied Aspects
- Demonstrate the preparation rather than describing it — one sachet dissolved in the stated volume of clean water. A more concentrated solution is dangerous, causing hypernatraemia and seizures, and is a common error when families assume "stronger is better"
- Home fluids are better than nothing — salted rice water, salted buttermilk, coconut water — but ORS is preferred where available
- Teach the danger signs that require return: sunken eyes, lethargy, inability to drink, reduced urine, blood in the stool, persistent vomiting, or fever
- ORS and zinc are supplied free through India's national programme, and the limiting factor is awareness rather than availability — ORS use remains well below what is achievable
- Diarrhoea remains a leading cause of under-five death in India, and almost all of it is preventable by ORS, zinc, rotavirus vaccination, safe water, sanitation and handwashing — none of which requires a hospital
- Do not give unnecessary antibiotics and antimotility drugs; they cause harm, cost money and displace the treatment that works
All questions in Gastrointestinal & Respiratory Drugs
- Q1Describe the physiology of gastric acid secretion. Classify the drugs used in peptic ulcer and reflux disease with their uses and adverse effects. ★
- Q2Describe the physiology of vomiting. Classify antiemetics and describe the choice of drug in different situations. ★
- Q3Classify laxatives and antidiarrhoeal drugs. Describe the drugs used in inflammatory bowel disease. ★
- Q4Classify the drugs used in bronchial asthma. Describe the stepwise management of chronic asthma and of acute severe asthma. ★
- Q5Describe the drugs used in COPD and cough. Describe the methylxanthines with their interactions and toxicity. ★
- SN1Describe the proton pump inhibitors with their mechanism, uses and adverse effects. ★
- SN2Describe the regimens used for Helicobacter pylori eradication and the principles of testing. ★
- SN3Describe the antiemetics used in chemotherapy-induced nausea and vomiting. ★
- SN4Describe the scientific basis, composition and use of oral rehydration therapy. ★
- SN5Describe theophylline with its mechanism, interactions, toxicity and place in therapy. ★
- SN6Describe the inhalational devices and the inhaled corticosteroids. ★
- SN7Describe the drugs used in hepatic encephalopathy and the principles of prescribing in chronic liver disease.